These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 9294704

  • 1. In vitro antimicrobial activity and MIC quality control guidelines of RPR 106972 (RPR 112808/RPR106950): a novel orally administered streptogramin combination. The Quality Control Study Group.
    Putnam SD, Jones RN, Johnson DM.
    Diagn Microbiol Infect Dis; 1997 Jul; 28(3):139-47. PubMed ID: 9294704
    [Abstract] [Full Text] [Related]

  • 2. Antimicrobial activity of quinupristin-dalfopristin (RP 59500, Synercid) tested against over 28,000 recent clinical isolates from 200 medical centers in the United States and Canada.
    Jones RN, Ballow CH, Biedenbach DJ, Deinhart JA, Schentag JJ.
    Diagn Microbiol Infect Dis; 1998 Jul; 31(3):437-51. PubMed ID: 9635235
    [Abstract] [Full Text] [Related]

  • 3. [Comparative antimicrobial activity of RP 59,500 (quinupristin-dalfopristin), the first semisynthetic injectable streptgramin, against gram-positive cocci and other recent clinical pathogens].
    Nakashio S, Iwasawa H, Iino S, Shimada J.
    Jpn J Antibiot; 1997 Oct; 50(10):844-53. PubMed ID: 9412874
    [Abstract] [Full Text] [Related]

  • 4. Antimicrobial susceptibility of quinupristin/dalfopristin tested against gram-positive cocci from Latin America: results from the global SMART (GSMART) surveillance study.
    Sader HS, Jones RN, Ballow CH, Biedenbach DJ, Cered RF, GSMART Latin America Study Group.
    Braz J Infect Dis; 2001 Feb; 5(1):21-31. PubMed ID: 11290311
    [Abstract] [Full Text] [Related]

  • 5. In vitro activity of quinupristin/dalfopristin against gram-positive bacteria Haemophilus influenzae and Branhamella catarrhalis in Taiwan.
    Wang FD, Lin ML, Liu CY.
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Jun; 63(6):433-9. PubMed ID: 10925532
    [Abstract] [Full Text] [Related]

  • 6. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1995). I. Susceptibility distribution].
    Kumamoto Y, Tsukamoto T, Hirose T, Yokoo A, Hikichi Y, Shigeta S, Takanashi T, Shiraiwa Y, Ogiwara M, Yoshida H, Imafuku Y, Murai M, Watanabe K, Uchida H, Kobayashi Y, Matsuda S, Fujime M, Fujita K, Igari J, Oguri T, Kosakai N, Yamaguchi K, Matsumoto T, Kashitani F, Tanaka M.
    Jpn J Antibiot; 1997 Mar; 50(3):219-50. PubMed ID: 9575353
    [Abstract] [Full Text] [Related]

  • 7. In vitro activity of quinupristin/dalfopristin against clinical isolates of common gram-positive bacteria in Taiwan.
    Chang SC, Fang CT, Hsueh PR, Luh KT, Hsieh WC.
    Diagn Microbiol Infect Dis; 1999 Apr; 33(4):299-303. PubMed ID: 10212757
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1994). I. Susceptibility distribution].
    Kumamoto Y, Hirose T, Yokoo A, Hikichi Y, Shigeta S, Shiraiwa Y, Kameoka H, Yoshida H, Tazaki H, Iri H, Uchida H, Kobayashi Y, Matsuda S, Fujime M, Fujita K, Kitagawa R, Igari J, Oguri T, Kosakai N, Yamaguchi K, Kashitani F, Yonezu S, Yamanaka Y, Takaha M, Iori F.
    Jpn J Antibiot; 1996 May; 49(5):465-93. PubMed ID: 8752862
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. In vitro evaluation of a novel ketolide antimicrobial agent, RU-64004.
    Jamjian C, Biedenbach DJ, Jones RN.
    Antimicrob Agents Chemother; 1997 Feb; 41(2):454-9. PubMed ID: 9021207
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Susceptibility to RPR 106,972, quinupristin/dalfopristin and erythromycin among recent clinical isolates of enterococci, staphylococci and streptococci from North American medical centres.
    Barry AL, Fuchs PC, Brown SD.
    J Antimicrob Chemother; 1998 Nov; 42(5):651-5. PubMed ID: 9848451
    [Abstract] [Full Text] [Related]

  • 15. MIC and time-kill study of antipneumococcal activities of RPR 106972 (a new oral streptogramin), RP 59500 (quinupristin-dalfopristin), pyostacine (RP 7293), penicillin G, cefotaxime, erythromycin, and clarithromycin against 10 penicillin-susceptible and -resistant pneumococci.
    Pankuch GA, Jacobs MR, Appelbaum PC.
    Antimicrob Agents Chemother; 1996 Sep; 40(9):2071-4. PubMed ID: 8878583
    [Abstract] [Full Text] [Related]

  • 16. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1989). I. Susceptibility distribution].
    Kumamoto Y, Hirose T, Tanaka N, Hikichi Y, Shigeta S, Shiraiwa Y, Kameoka H, Yoshida H, Ogata M, Tazaki H.
    Jpn J Antibiot; 1995 Sep; 48(9):1131-60. PubMed ID: 7474333
    [Abstract] [Full Text] [Related]

  • 17. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1996). I. Susceptibility distribution].
    Kumamoto Y, Tsukamoto T, Hirose T, Yokoo A, Shigeta S, Takahashi T, Shiraiwa Y, Ogiwara M, Yoshida H, Imafuku Y, Murai M, Watanabe K, Uchida H, Kobayashi Y, Matsuda S, Fujime M, Fujita K, Igari J, Oguri T, Yamaguchi K, Matsumoto T, Kashitani F, Kaku M, Ooe H, Mochida C.
    Jpn J Antibiot; 1998 Feb; 51(2):69-111. PubMed ID: 9575437
    [Abstract] [Full Text] [Related]

  • 18. Spectrum and antimicrobial activity of alexomycin (PNU-82, 127), a peptide compound projected for use in animal health.
    Marshall SA, Jones RN.
    Diagn Microbiol Infect Dis; 1999 Mar; 33(3):181-6. PubMed ID: 10092967
    [Abstract] [Full Text] [Related]

  • 19. Antimicrobial activity of doripenem (S-4661): a global surveillance report (2003).
    Fritsche TR, Stilwell MG, Jones RN.
    Clin Microbiol Infect; 2005 Dec; 11(12):974-84. PubMed ID: 16307551
    [Abstract] [Full Text] [Related]

  • 20. Comparative activity of quinupristin/dalfopristin and RPR 106972 and the effect of medium on in-vitro test results.
    King A, May J, Phillips I.
    J Antimicrob Chemother; 1998 Dec; 42(6):711-9. PubMed ID: 10052893
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.